U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H20F2N2O4
Molecular Weight 426.4127
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GARENOXACIN

SMILES

C[C@H]1NCC2=CC(=CC=C12)C3=CC=C4C(=O)C(=CN(C5CC5)C4=C3OC(F)F)C(O)=O

InChI

InChIKey=NJDRXTDGYFKORP-LLVKDONJSA-N
InChI=1S/C23H20F2N2O4/c1-11-15-5-2-12(8-13(15)9-26-11)16-6-7-17-19(21(16)31-23(24)25)27(14-3-4-14)10-18(20(17)28)22(29)30/h2,5-8,10-11,14,23,26H,3-4,9H2,1H3,(H,29,30)/t11-/m1/s1

HIDE SMILES / InChI

Molecular Formula C23H20F2N2O4
Molecular Weight 426.4127
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:38:20 UTC 2023
Edited
by admin
on Sat Dec 16 17:38:20 UTC 2023
Record UNII
V72H9867WB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GARENOXACIN
INN   MART.   MI   WHO-DD  
INN  
Official Name English
GARENOXACIN [MI]
Common Name English
GARENOXACIN [MART.]
Common Name English
Garenoxacin [WHO-DD]
Common Name English
T-3811
Code English
garenoxacin [INN]
Common Name English
Classification Tree Code System Code
WHO-VATC QJ01MA19
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
NCI_THESAURUS C795
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
WHO-ATC J01MA19
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
Code System Code Type Description
SMS_ID
100000091588
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
MERCK INDEX
m5672
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY Merck Index
CAS
194804-75-6
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
INN
8237
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
FDA UNII
V72H9867WB
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
WIKIPEDIA
Garenoxacin
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
NCI_THESAURUS
C65800
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
EVMPD
SUB25475
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID30173135
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
DRUG CENTRAL
4053
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
ChEMBL
CHEMBL215303
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
MESH
C419689
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
DRUG BANK
DB06160
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
PUBCHEM
124093
Created by admin on Sat Dec 16 17:38:22 UTC 2023 , Edited by admin on Sat Dec 16 17:38:22 UTC 2023
PRIMARY
Related Record Type Details
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
Related Record Type Details
ACTIVE MOIETY